Evaluation: 2024 March Cosmetics Webinar
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
Evaluation: 2024 March Introduction to Biologics
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
An Introduction to Violations, Enforcement, and International Issues in Biologics and Biosimilars
An Introduction to Violations, Enforcement, and International Issues in Biologics and Biosimilars A session from FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 An Introduction to Violations, Enforcement, and International Issues in Biologics and Biosimilars Learn [...]
The Regulation of Biological Product Marketing: An Introduction
The Regulation of Biological Product Marketing: An Introduction A session from FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 The Regulation of Biological Product Marketing: An Introduction Learn the legal and regulatory requirements surrounding communications about [...]
The Regulation of Biological Product Manufacturing: An Introduction
The Regulation of Biological Product Manufacturing: An Introduction A session from FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 The Regulation of Biological Product Manufacturing: An Introduction Examine requirements for establishment registration and listing. Learn about [...]
Post-Approval Pharmacovigilance of Biological Products: An Introduction
Post-Approval Pharmacovigilance of Biological Products: An Introduction A session from FDLI's Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 Post-Approval Pharmacovigilance of Biological Products: An Introduction Learn the regulatory basis of post-marketing adverse event reporting and become [...]
Biologics and Biosimilars: An Introduction
Biosimilar Biological Products: An Introduction A session from FDLI's Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 Biosimilar Biological Products: An Introduction Understand background and definitions of biologic and biosimilar drugs and new drug applications (NDAs) and [...]
Biological Product Approval, Vaccines, Emergency Use Authorization: An Introduction
Biological Product Approval, Vaccines, Emergency Use Authorization: An Introduction A session from FDLI's Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 Biological Product Approval, Vaccines, Emergency Use Authorization: An Introduction Learn about the Biologics License Application (BLA) [...]
Introduction to Human Cellular and Tissue Based Products (HCT/P), Cell Therapy and Gene Therapy
Introduction to Human Cellular and Tissue Based Products (HCT/P), Cell Therapy and Gene Therapy A session from FDLI's Introduction to Biological Products, Including Vaccines, Biosimilars, Cell and Gene Therapies, and Other Advanced Therapies Recorded March 5–6, 2024 Introduction to Human Cellular and Tissue Based Products [...]
Regulation of Biological Product/Drug Development: An Introduction
Regulation of Biological Product/Drug Development: An Introduction A session from FDLI's FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 Regulation of Biological Product/Drug Development: An Introduction Summarize preclinical and clinical testing, sources of Good Clinical Practice [...]
